Literature DB >> 18987494

Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development.

L Lin1, J C Achermann.   

Abstract

Steroidogenic factor-1 (SF-1) (Ad4BP, NR5A1) is a nuclear receptor that regulates many aspects of adrenal and reproductive development and function. Consequently, deletion of the gene (Nr5a1) encoding Sf-1 in XY mice results in impaired adrenal development, complete testicular dysgenesis with Mullerian structures, and female external genitalia. Initial efforts to identify NR5A1 changes in humans focused on 46,XY individuals with combined adrenogonadal failure and Mullerian structures. Although this combination of clinical features is rare, 2 such patients harboring NR5A1 mutations have been described within the past decade. More recently, however, it has emerged that heterozygous loss of function mutations in NR5A1 can be found relatively frequently in children and adults with 46,XY disorders of sex development (DSD) but with apparently normal adrenal function. The phenotypic spectrum associated with these changes ranges from complete testicular dysgenesis with Mullerian structures, through individuals with mild clitoromegaly or genital ambiguity, to severe penoscrotal hypospadias or even anorchia. Furthermore, a non-synonymous polymorphism in NR5A1 may be associated with micropenis or undescended testes within the population. Taken together, these reports suggest that variable loss of SF-1 function can be associated with a wide range of reproductive phenotypes in humans. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987494      PMCID: PMC2645687          DOI: 10.1159/000152036

Source DB:  PubMed          Journal:  Sex Dev        ISSN: 1661-5425            Impact factor:   1.824


  73 in total

1.  Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of the DNA binding domain is necessary for complex stability.

Authors:  Tanya H Little; Yongbo Zhang; Christina K Matulis; Jennifer Weck; Zhipeng Zhang; Aparna Ramachandran; Kelly E Mayo; Ishwar Radhakrishnan
Journal:  Mol Endocrinol       Date:  2005-12-08

2.  Foxl2 up-regulates aromatase gene transcription in a female-specific manner by binding to the promoter as well as interacting with ad4 binding protein/steroidogenic factor 1.

Authors:  De-Shou Wang; Tohru Kobayashi; Lin-Yan Zhou; Bindhu Paul-Prasanth; Shigeho Ijiri; Fumie Sakai; Kataaki Okubo; Ken-ichirou Morohashi; Yoshitaka Nagahama
Journal:  Mol Endocrinol       Date:  2006-12-27

3.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

4.  Association of cryptorchidism with Gly146Ala polymorphism in the gene for steroidogenic factor-1.

Authors:  Yuka Wada; Michiyo Okada; Maki Fukami; Isoji Sasagawa; Tsutomu Ogata
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

5.  Ovotestes and XY sex reversal in a female with an interstitial 9q33.3-q34.1 deletion encompassing NR5A1 and LMX1B causing features of Genitopatellar syndrome.

Authors:  Silke Schlaubitz; Svetlana A Yatsenko; Laurie D Smith; Kory L Keller; Lisenka E Vissers; Daryl A Scott; Wei Wen Cai; William Reardon; Omar A Abdul-Rahman; Edward J Lammer; Caroline A Lifchez; Ellen Magenis; Joris A Veltman; Pawel Stankiewicz; Bernhard U Zabel; Brendan Lee
Journal:  Am J Med Genet A       Date:  2007-05-15       Impact factor: 2.802

6.  Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1.

Authors:  Mohamad Zubair; Satoru Ishihara; Sanae Oka; Katsuzumi Okumura; Ken-ichirou Morohashi
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

7.  Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1.

Authors:  Richard J Whitby; Sally Dixon; Patrick R Maloney; Philippe Delerive; Bryan J Goodwin; Derek J Parks; Timothy M Willson
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

8.  A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency.

Authors:  Anne L Reuter; Katsumi Goji; Nathan C Bingham; Masafumi Matsuo; Keith L Parker
Journal:  Eur J Endocrinol       Date:  2007-08       Impact factor: 6.664

9.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Authors:  Lin Lin; Wen-Xia Gu; Gokhan Ozisik; Wing S To; Catherine J Owen; J Larry Jameson; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

10.  Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage.

Authors:  Pierre Val; Juan-Pedro Martinez-Barbera; Amanda Swain
Journal:  Development       Date:  2007-06       Impact factor: 6.868

View more
  56 in total

1.  Complete XY gonadal dysgenesis due to p.D293N homozygous mutation in the NR5A1 gene: a case study.

Authors:  F C Soardi; F Borchers Coeli; A T Maciel-Guerra; G Guerra-Júnior; M Palandi de Mello
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 2.  The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.

Authors:  Sang Jun Han; Bert W O'Malley
Journal:  Hum Reprod Update       Date:  2014-03-14       Impact factor: 15.610

3.  Steroidogenic Factor 1 (NR5A1) resides in centrosomes and maintains genomic stability by controlling centrosome homeostasis.

Authors:  P-Y Lai; C-Y Wang; W-Y Chen; Y-H Kao; H-M Tsai; T Tachibana; W-C Chang; B-c Chung
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

4.  Development of a novel next-generation sequencing panel for diagnosis of quantitative spermatogenic impairment.

Authors:  Maria Santa Rocca; Aichi Msaki; Marco Ghezzi; Ilaria Cosci; Kalliopi Pilichou; Rudy Celeghin; Carlo Foresta; Alberto Ferlin
Journal:  J Assist Reprod Genet       Date:  2020-04-03       Impact factor: 3.412

Review 5.  Holistic management of DSD.

Authors:  Caroline E Brain; Sarah M Creighton; Imran Mushtaq; Polly A Carmichael; Angela Barnicoat; John W Honour; Victor Larcher; John C Achermann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-04       Impact factor: 4.690

6.  SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1.

Authors:  Megumi Hatano; Toshiro Migita; Tomokazu Ohishi; Yuichi Shima; Yoshihiro Ogawa; Ken-Ichirou Morohashi; Yukihiro Hasegawa; Futoshi Shibasaki
Journal:  Endocrine       Date:  2016-07-25       Impact factor: 3.633

Review 7.  Steroidogenic factor-1 and human disease.

Authors:  Ranna El-Khairi; John C Achermann
Journal:  Semin Reprod Med       Date:  2012-10-08       Impact factor: 1.303

Review 8.  Phospholipid--driven gene regulation.

Authors:  Paul M Musille; Jeffrey A Kohn; Eric A Ortlund
Journal:  FEBS Lett       Date:  2013-01-16       Impact factor: 4.124

9.  Histological and Transcriptomic Changes in Male Zebrafish Testes Due to Early Life Exposure to Low Level 2,3,7,8-Tetrachlorodibenzo-p-Dioxin.

Authors:  Bridget B Baker; Jeremiah S Yee; Danielle N Meyer; Doris Yang; Tracie R Baker
Journal:  Zebrafish       Date:  2016-10       Impact factor: 1.985

10.  The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Inas Mazen; Cigdem Cetindag; Heike Biebermann; Ilker Akkurt; Rainer Rossi; Olaf Hiort; Annette Grüters; John C Achermann
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.